Unknown OBSERVATIONAL NCT00339001

Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity

Sponsor: Sheba Medical Center

Conditions Retinopathy of Prematurity

Interventions erythropoietin and early iron supplements

Updated 6 times since 2017 Last updated: Jun 19, 2006 Started: Apr 30, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Retinopathy of Prematurity, this trial is ongoing. The trial is conducted by Sheba Medical Center and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sheba Medical Center

Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ramat Gan, Israel